Skip to content

Cauda equina syndrome early recognition study

The Cauda Equina Syndrome Early Recognition (CESER) Study: a mixed-methods study to improve diagnosis of cauda equina syndrome in the Emergency Department

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN55506796
Enrollment
2000
Registered
2026-04-13
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cauda equina syndrome (CES) Nervous System Diseases

Interventions

The study is a multi-centre prospective diagnostic cohort study. The study will recruit up to 2000 patients with suspected CES from approximately 12 trial locations in the UK. Participants with conf

Sponsors

University of Oxford
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 120 Years

Inclusion criteria

Inclusion criteria: 1. They are aged 18 years or over 2. They have a suspected diagnosis of CES, defined by a clinician who routinely assesses such patients and considers it appropriate to organise an MRI to confirm or exclude this diagnosis 3. They are willing and able to give informed consent

Exclusion criteria

Exclusion criteria: 1. The MRI scan for suspected cauda equina compression had been undertaken before the clinical assessment 2. There is a suspected spinal fracture 3. There is evidence that the patient will be unable to adhere to trial procedures or participate in follow-up, including life expectancy of less than 12 months

Countries

England, Scotland, United Kingdom, Wales

Contacts

Public ContactKylea Draper- Kadoorie
ceser@ndorms.ox.ac.uk+44 01865 223126 (Mon, Tue and Thu Only), +44 07392165324 (Wed and Fri Only)

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: May 1, 2026